Latest Breaking News On - Surgery after treatment - Page 1 : vimarsana.com

31.10.2023 - ATLANTA, Oct. 31, 2023 (GLOBE NEWSWIRE) - Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining .

Czech republicUnited statesScott gordonDavid chin yeeJules abrahamDaniel kiernanMathew maccumberAlimera sciences incAlimera sciencesEyes requiringSurgery after treatmentAcetonide implantPoster sessionFluocinolone acetonide implant leadsBetter baseline visual acuityPhd control